Camelot Portfolios Cut Glaxosmithkline Plc (Gsk) (GSK) Position; 8 Bullish Analysts Covering Whiting Petroleum (WLL)

June 21, 2017 - By Maria Brooks

Among 32 analysts covering Whiting Petroleum Corporation (NYSE:WLL), 8 have Buy rating, 5 Sell and 19 Hold. Therefore 25% are positive. Whiting Petroleum Corporation had 94 analyst reports since July 21, 2015 according to SRatingsIntel. Iberia Capital Partners upgraded Whiting Petroleum Corp (NYSE:WLL) rating on Friday, March 11. Iberia Capital Partners has “Outperform” rating and $15 target. The company was maintained on Tuesday, June 14 by Deutsche Bank. The firm has “Sector Perform” rating by Iberia Capital Partners given on Monday, May 15. The firm has “Buy” rating by Citigroup given on Monday, September 14. As per Friday, April 29, the company rating was downgraded by Sterne Agee CRT. The rating was maintained by RBC Capital Markets on Friday, June 2 with “Hold”. The firm has “Neutral” rating by Seaport Global given on Thursday, February 25. Cowen & Co maintained the stock with “Outperform” rating in Friday, March 18 report. The rating was reinitiated by IBERIA on Wednesday, September 2 with “Sector Perform”. As per Thursday, October 6, the company rating was initiated by Mizuho. See Whiting Petroleum Corp (NYSE:WLL) latest ratings:

02/06/2017 Broker: RBC Capital Markets Rating: Hold New Target: $12.0000 Maintain
02/06/2017 Broker: Credit Suisse Old Rating: Outperform New Rating: Neutral New Target: $13 Downgrade
30/05/2017 Broker: Goldman Sachs Old Rating: Neutral New Rating: Sell Downgrade
15/05/2017 Broker: Iberia Capital Partners Rating: Sector Perform New Target: $10.00 Maintain
10/05/2017 Broker: FBR Capital Rating: Mkt Perform Old Target: $13.00 New Target: $11.00 Maintain
28/04/2017 Broker: R. F. Lafferty Rating: Buy Old Target: $14.00 New Target: $15.00 Target Up
26/04/2017 Broker: RBC Capital Markets Rating: Hold New Target: $12.00 Target
21/04/2017 Broker: Barclays Capital Rating: Hold New Target: $10.00 Maintain
03/04/2017 Broker: Credit Suisse Rating: Buy New Target: $15.00 Maintain
23/03/2017 Broker: UBS Old Rating: Neutral New Rating: Sell Downgrade

Camelot Portfolios Llc decreased Glaxosmithkline Plc (Gsk) (GSK) stake by 31% reported in 2016Q4 SEC filing. Camelot Portfolios Llc sold 9,283 shares as Glaxosmithkline Plc (Gsk) (GSK)’s stock rose 5.47%. The Camelot Portfolios Llc holds 20,666 shares with $796,000 value, down from 29,949 last quarter. Glaxosmithkline Plc (Gsk) now has $105.44 billion valuation. The stock decreased 0.91% or $0.4 during the last trading session, reaching $43.38. About 2,900 shares traded. GlaxoSmithKline plc (ADR) (NYSE:GSK) has risen 4.26% since June 21, 2016 and is uptrending. It has underperformed by 12.44% the S&P500.

Analysts await GlaxoSmithKline plc (ADR) (NYSE:GSK) to report earnings on July, 26. They expect $0.71 earnings per share, up 1.43% or $0.01 from last year’s $0.7 per share. GSK’s profit will be $1.73B for 15.27 P/E if the $0.71 EPS becomes a reality. After $0.62 actual earnings per share reported by GlaxoSmithKline plc (ADR) for the previous quarter, Wall Street now forecasts 14.52% EPS growth.

Camelot Portfolios Llc increased Kayne Anderson Energy Total Return (Kye) (KYE) stake by 33,996 shares to 482,577 valued at $5.70M in 2016Q4. It also upped First Trust High Income Long/Short Fund (Fsd) (FSD) stake by 49,907 shares and now owns 672,551 shares. Cohen & Steers Reit & Preferred Income (Rnp) (RNP) was raised too.

Among 13 analysts covering GlaxoSmithKline (NYSE:GSK), 7 have Buy rating, 0 Sell and 6 Hold. Therefore 54% are positive. GlaxoSmithKline had 20 analyst reports since September 8, 2015 according to SRatingsIntel. On Wednesday, April 5 the stock rating was upgraded by BNP Paribas to “Neutral”. The firm has “Neutral” rating by BNP Paribas given on Tuesday, September 15. As per Friday, August 12, the company rating was maintained by Argus Research. As per Thursday, July 14, the company rating was upgraded by Jefferies. The firm earned “Buy” rating on Thursday, October 20 by Investec. Argus Research maintained GlaxoSmithKline plc (ADR) (NYSE:GSK) on Monday, December 7 with “Buy” rating. The firm has “Neutral” rating by Credit Suisse given on Tuesday, October 20. The rating was initiated by Piperjaffray on Friday, September 23 with “Overweight”. The firm has “Hold” rating by Cantor Fitzgerald given on Friday, February 26. The rating was upgraded by Berenberg on Friday, May 26 to “Buy”.

Whiting Petroleum Corporation is an independent gas and oil company. The company has market cap of $2.07 billion. The Firm is engaged in development, production, acquisition and exploration activities primarily in the Rocky Mountains region of the United States. It currently has negative earnings. It is engaged in the exploration and production of crude oil, natural gas liquid and natural gas.

Investors sentiment decreased to 1.17 in Q4 2016. Its down 0.14, from 1.31 in 2016Q3. It is negative, as 35 investors sold Whiting Petroleum Corp shares while 97 reduced holdings. 62 funds opened positions while 93 raised stakes. 284.48 million shares or 9.51% more from 259.76 million shares in 2016Q3 were reported. Leavell Inv Incorporated holds 0.02% or 10,100 shares. Fmr Ltd Llc has invested 0.04% in Whiting Petroleum Corp (NYSE:WLL). California Pub Employees Retirement Systems invested in 933,198 shares. Voya Inv Mngmt Limited Liability Corporation holds 0% in Whiting Petroleum Corp (NYSE:WLL) or 63,127 shares. M&T National Bank & Trust reported 19,966 shares. Gabelli Funds Ltd Co reported 0.01% stake. Barclays Plc reported 0.01% of its portfolio in Whiting Petroleum Corp (NYSE:WLL). Neuberger Berman Group Limited Liability Company reported 0% in Whiting Petroleum Corp (NYSE:WLL). Cubist Systematic Strategies Ltd holds 0% or 1,129 shares in its portfolio. Bluestein R H holds 0.02% of its portfolio in Whiting Petroleum Corp (NYSE:WLL) for 20,000 shares. Gamco Invsts Inc Et Al has 180,000 shares. Monarch Cap Management owns 14,250 shares for 0.06% of their portfolio. Van Eck invested in 42,680 shares or 0% of the stock. Rmb Capital Mngmt Limited Liability Corp has 0.08% invested in Whiting Petroleum Corp (NYSE:WLL). Moreover, Nelson Van Denburg Campbell Wealth Mgmt Grp Lc has 0% invested in Whiting Petroleum Corp (NYSE:WLL) for 325 shares.